Table 3.
Maximum Dean Scorea | Hair Loss, % | Scalp Cooling Group (n = 101)b | Control Group (n = 16) | P Valuec | ||
---|---|---|---|---|---|---|
No. of Patients | % (95% CI) | No. of Patients | % (95% CI) | |||
0 | 0 | 5 | 5.0 (1.6–11.2) | 0 | <.001 | |
1 | >0–≤25 | 31 | 30.7 (21.9–40.7) | 0 | ||
2 | >25–≤50 | 31 | 30.7 (21.9–40.7) | 0 | ||
3 | >50–≤75 | 19 | 18.8 (11.7–27.8) | 1 | 6.3 (0–30.2) | |
4 | >75 | 15 | 14.9 (8.6–23.3) | 15 | 93.8 (69.8–99.8) | |
0–2 | 0–≤50 | 67 | 66.3 (56.2–75.4) | 0 | <.001 | |
≥3 | >50 | 34 | 33.7 (24.6–43.8) | 16 | 100.0 (79.4–100.0) |
Indicates highest score measured during the study up to 4 weeks after last chemotherapy treatment. A score of less than 3 indicates that the treatment was a success; a score of equal to or greater than 3 indicates that the treatment was a failure.
There were 5 patients who were not included in the primary analysis.
Calculated using the Fisher exact test.